Results 341 to 350 of about 212,465 (393)
Some of the next articles are maybe not open access.
Neuropeptide Y Y1 receptors in vascular pharmacology
European Journal of Pharmacology, 1998The existence of neurogenic mediator candidates apart from noradrenaline and acetylcholine involved in the control of vascular tone has attracted enormous attention during the past few decades. One such mediator is neuropeptide Y (NPY), which is co-localized with noradrenaline in sympathetic perivascular nerves.
Jan Liska, Anders Franco-Cereceda
openaire +2 more sources
The control of bone remodeling by neuropeptide Y receptors
Peptides, 2007An important role for the neuropeptide Y receptor system in the regulation of bone formation was recently revealed with a significant elevation in trabecular bone formation and bone volume following germline or hypothalamus-specific deletion of neuropeptide Y2 receptors in mice.
Susan J. Allison+2 more
openaire +3 more sources
Neuropeptide Y as a partial agonist of the Y1 receptor
European Journal of Pharmacology, 2005In absence of receptor cycling, human/rat neuropeptide Y was found to persistently occupy the guinea pig neuropeptide Y Y1 receptors expressed on the surface of Chinese hamster ovary (CHO) cells (IC50 approximately 8 nM); a lasting occupancy was also evident with active receptor cycling.
Michael S. Parker+4 more
openaire +3 more sources
Galanin receptor/neuropeptide y receptor interactions in the central nervous system.
Current protein and peptide science, 2013The presence of Galanin and Neuropeptide Y and/or their receptors in several areas of the brain involved in memory, mood, cardiovascular control and food intake indicates that Galanin, and Neuropeptide Y could equilibrate the physiological actions of ...
Z. Díaz-Cabiale+8 more
semanticscholar +1 more source
Neuropeptide Y receptor gene y6: multiple deaths or resurrections?
Biochemical and Biophysical Research Communications - BBRC, 2000The neuropeptide Y family of G-protein-coupled receptors consists of five cloned members in mammals. Four genes give rise to functional receptors in all mammals investigated.
P. Starbäck+3 more
semanticscholar +1 more source
Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release
European Journal of Pharmacology, 2000We have examined the selective neuropeptide Y Y(2) receptor antagonist, (S)-N(2)-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6h)-oxodibenz[b, e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl ]-N-[2-[1 ,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3-H-1,2, 4-triazol-4-yl]ethyl]-argininamid (BIIE0246) on neuropeptide release from rat hypothalamic slices in vitro.
Peter S. Widdowson+3 more
openaire +3 more sources
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor
European Journal of Pharmacology, 1996To elucidate which neuropeptide Y receptor subtype is responsible for the neuropeptide Y-induced potentiation of the noradrenaline-evoked contraction in human omental arteries we used antisense oligodeoxynucleotide (Antisense), the new selective neuropeptide Y Y1 receptor antagonist, BIBP3226 {(R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl) methyl]-D ...
Torun Nilsson+15 more
openaire +3 more sources
Journal of Medicinal Chemistry, 2011
Nontoxic ortho-carbaborane is one of the most promising structure for boron neutron capture therapy (BNCT). For directed uptake of ortho-carbaborane by tumor cells, receptor-subtype selective neuropeptide Y (NPY) and its derivatives were modified with ...
Verena M. Ahrens+4 more
semanticscholar +1 more source
Nontoxic ortho-carbaborane is one of the most promising structure for boron neutron capture therapy (BNCT). For directed uptake of ortho-carbaborane by tumor cells, receptor-subtype selective neuropeptide Y (NPY) and its derivatives were modified with ...
Verena M. Ahrens+4 more
semanticscholar +1 more source
Emerging functions of neuropeptide Y Y2 receptors in the brain
Peptides, 2001The Y(2) receptor is the predominant neuropeptide Y (NPY) receptor subtype in the brain. Y(2) receptor mRNA is discretely distributed in the brain, including specific subregions of the hippocampus and the hypothalamus, and is largely consistent with the distribution of Y(2) receptor protein demonstrated by radioligand-binding methods.
Akio Inui, Toshiro Kaga, Mineko Fujimiya
openaire +3 more sources
Pharmacological characterization of the cloned neuropeptide Y y6 receptor
European Journal of Pharmacology, 2000Neuropeptide Y has potent appetite stimulating effects which are mediated by hypothalamic receptors believed to be of the neuropeptide Y Y(1) and/or neuropeptide Y Y(5) subtype. In mice, the neuropeptide Y y(6) receptor is also expressed in the hypothalamus, suggesting that it too may function as a feeding receptor in this species. Several laboratories
Mario Guzzi+3 more
openaire +3 more sources